2006-May Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Mon May 1 06:01:16 2006
Ending: Wed May 31 19:51:37 2006
Messages: 205

• [Ip-health] IP-Watch on CIPIH and R&D resolutions   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] MSF and DNDi in Lancet: Global framework on essential health R&D   James ARKINSTALL
• [Ip-health] US 2006 Special 301 Report: Data Exclusivity and Linkage   B.Baker@neu.edu
• [Ip-health] IP-Watch: Pfizer Fights IP Flexibilities In The Philippines   Thiru Balasubramaniam
• [Ip-health] Barbour, Chinnock, Cohen and Yamey in the WHO Bulletin: The impact of open access upon public health   Thiru Balasubramaniam
• [Ip-health] Sisule Musungu (abstract) in the WHO Bulletin: Benchmarking progress in tackling the challenges of intellectual property, and access to medicines in developing countries   Thiru Balasubramaniam
• [Ip-health] Vasan et. al in the WHO Bulletin: The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund   Thiru Balasubramaniam
• [Ip-health] James Love in the WHO Bulletin: Drug development to improve access to essential medicines   Thiru Balasubramaniam
• [Ip-health] Ellen 't Hoen in the WHO Bulletin: Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments   Thiru Balasubramaniam
• [Ip-health] Carlos Correa in the WHO Bulletin (abstract): Implications of bilateral free trade agreements on access to medicines   Thiru Balasubramaniam
• [Ip-health] Financial Times: Indian Aids victims in patents protest   Thiru Balasubramaniam
• [Ip-health] Tomris Turmen and Charles Clift in the WHO Bulletin: Public health, innovation and intellectual property rights: unfinished business   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Generics Work Against Bird Flu   Thiru Balasubramaniam
• [Ip-health] New York Times: AIDS Groups in India Sue to Halt Patent for U.S. Drug   Thiru Balasubramaniam
• [Ip-health] FromGeneva: Libertarian think tank (IPN) throws drinks/canapes bash on eve of World Health Assembly   Thiru Balasubramaniam
• [Ip-health] Presentation by Nigeria to WIPO Advisory Committee on Enforcement (Monday, 15 May 2006)   Thiru Balasubramaniam
• [Ip-health] FromGeneva: WIPO hosts enforcement beauty contest (aka Advisory Committtee on Enforcement)   Thiru Balasubramaniam
• [Ip-health] FromGeneva: US delegation opposes consumer groups' inclusion on WIPO ACE panels   Thiru Balasubramaniam
• [Ip-health] IP-Watch: WIPO Discusses Enforcement As Some Seek Broader Mandate, Consumer Voice   Thiru Balasubramaniam
• [Ip-health] 64 MEPs Call to the World Health Assembly, to the European Commission, the Council and to the national governments for a   Thiru Balasubramaniam
• [Ip-health] l'Agence Telegraphique Suisse: Assemblee mondiale de la sante Polemique sur le rapport de Ruth Dreifuss   Thiru Balasubramaniam
• [Ip-health] Inter Press Service News (IPS): WHO Assembly to Face Controversies Over Patents, Taiwan   Thiru Balasubramaniam
• [Ip-health] WHO: Dr. Anders Nordstrom becomes Acting Director-General of the World Health Organization   Thiru Balasubramaniam
• [Ip-health] TOMORROW @ World Health Assembly: CI/CPTech Briefing on a Global Framework for Essential Health Research and Development   Thiru Balasubramaniam
• [Ip-health] IP-Watch: US Declares Opposition To WHO R&D Resolution As Proponents Raise Questions   Thiru Balasubramaniam
• [Ip-health] Financial Times: WHO in turmoil after sudden death of leader   Thiru Balasubramaniam
• [Ip-health] WHO report of the Executive Board meeting on the CIPIH report (A59/16) Add.1   Thiru Balasubramaniam
• [Ip-health] Unofficial English translation of "DECLARATION OF MINISTERS OF SOUTH AMERICA OVER INTELLECTUAL PROPERTY, ACCESS TO MEDICINES AND PUBLIC HEALTH"   Thiru Balasubramaniam
• [Ip-health] World Health Assembly discusses global framework on essential R&D resolution and public health, innovation and IP resolution tomorrow   Thiru Balasubramaniam
• [Ip-health] Comparison of EC and Industry positions on WHA R&D resolution   Thiru Balasubramaniam
• [Ip-health] TODAY @ World Health Assembly: Consumers International/CPTech briefing on New Approaches to stimulating Medical Research and Development   Thiru Balasubramaniam
• [Ip-health] Public interest NGO quotes on WHO R&D resolution (EB117.R13)   Thiru Balasubramaniam
• [Ip-health] Rowan Gillies and Ellen T Hoen in the Financial Times: Patients' needs are what must drive drug research   Thiru Balasubramaniam
• [Ip-health] The Times: Sleaze curbs to prevent firms from 'buying' MPs   Thiru Balasubramaniam
• [Ip-health] Extracts of operative paragraphs of WHO "Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action"   Thiru Balasubramaniam
• [Ip-health] Financial Times: WHO to prompt R&D for poorer countries   Thiru Balasubramaniam
• [Ip-health] AP: WHO Puts Roche on Alert for Tamiflu Stockpile   Thiru Balasubramaniam
• [Ip-health] Unofficial version of WHO resolution on "Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action"   Thiru Balasubramaniam
• [Ip-health] WHO statement: New Director-General of the World Health Organization to be chosen in November, 2006   Thiru Balasubramaniam
• [Ip-health] IP-Watch: World Health Organization To Elect New Director General In November   Thiru Balasubramaniam
• [Ip-health] EFTA-Korea FTA provisions on undisclosed information   Thiru Balasubramaniam
• [Ip-health] Patents, trade, and The Conservative Nanny State   Dan Beeton
• [Ip-health] Re: [A2k] IPR & competitiveness [Job and Growth Initiative] - EU Memo]   Ian Brown
• [Ip-health] IPR & competitiveness [Job and Growth Initiative] - EU Memo]   Michelle Childs
• [Ip-health] speech by eu commission president on role of private sector in the fight against hiv   Michelle Childs
• [Ip-health] EC asked to investigate possible undue influence by pharmaceutical industry lobbyists on WHA R&D resolution   Michelle Childs
• [Ip-health] DG Trade: call for proposals for activities to raise awareness of trade issues and enhance expertise has been launched.   Michelle Childs
• [Ip-health] SEMINAR ON CIPIH REPORT/WHO BULLETIN SPECIAL ISSUE: 9 MAY AT WHO   Clift, Charles
• [Ip-health] E-DRUG: EU Regulation text on compulsory licensing of patents   Philip Coticelli
• [Ip-health] Statement made at WHA on R&D   Colleen Daniels
• [Ip-health] World Health Assembly, governments rise to the occasion and work together for health   Colleen Daniels
• [Ip-health] Financial Times: WHO in turmoil after sudden death of leader   Nicoletta Dentico
• [Ip-health] Declaration of the Ministers of Health from South American Countries on TRIPs and access to medicines   Nicoletta Dentico
• [Ip-health] 3D - > Trade - Human Rights - Equitable Economy / Annual Report 2005   3D -> Trade - Human Rights - Equitable Economy
• [Ip-health] Re: US Drug Company Uses New Review for PBAC Decision   Tom Faunce
• [Ip-health] CT TO DECIDE USTR SUIT   Flynn, Sean M.
• [Ip-health] Eli Lilly CEO to Appear in DC May 10   Flynn, Sean M.
• [Ip-health] Lilly sues Ausies under U.S.-Aust FTA   Flynn, Sean M.
• [Ip-health] State legislators met on drug prices, trade   Flynn, Sean M.
• [Ip-health] CEIL IP Atty Vacancv, Geneva   Flynn, Sean M.
• [Ip-health] BMJ: Half a million children a year die of AIDS through lack of drugs   Nathan Ford
• [Ip-health] New article on 'Health Care and Access to Patented Technologies'   Kathryn Garforth
• [Ip-health] Panadol given to Zimbabwe's Aids patients as life-saving drugs run out   Ira Glazer
• [Ip-health] Avian Flu Wanes in Asian Nations It First Hit Hard   Ira Glazer
• [Ip-health] The Independent: Drug companies 'failing to meet health needs of world's poorest'   Ira Glazer
• [Ip-health] India has most Aids infections   Ira Glazer
• [Ip-health] HIV infection rates raise fears of Aids catastrophe in Russia   Ira Glazer
• [Ip-health] The EU Regulation text on compulsory licensing of patents relating to the manufacture of pharmacutical products for export countries with public health adopted but the EU on April 27th, 2006.   Alexandra HEUMBER
• [Ip-health] MSF hosts briefing on CIPIH report on 19 May   Ellen T HOEN
• [Ip-health] NEWS on European Commission position at the WHA   Ellen 't Hoen
• [Ip-health] Taxpayer Waste Group Criticizes World Health Organization   Jordan
• [Ip-health] Hudson Institue Seminar on WHO   Jordan
• [Ip-health] Panel Faults Pfizer in '96 Clinical Trial In Nigeria,Unapproved Drug Tested on Children   Jordan
• [Ip-health] Hudson Institute's Carol Adelman in the IHT on the WHO   Jordan
• [Ip-health] International Policy Network's "Independence and Guiding Principles"   Julian
• [Ip-health] International Policy Network's "Independence and Guiding Principles"   Julian
• [Ip-health] IPN is not a front group, is CPTech?   Julian
• [Ip-health] BMJ: Half a million children a year die of AIDS through lack of drugs   Julian
• [Ip-health] WSJ: Despite Hope, Decade of Delay Afflicts Drug to Prevent AIDS (Amy Nunn)   K.Shadlen@lse.ac.uk
• [Ip-health] Christian Israel, US Coordinator for International IPR on the IP enforcement in India   Gopa Kumar
• [Ip-health] US-Colombia FTA text   GRAIN LB
• [Ip-health] Invitation to Patients not Patents Mailing List   Jeffrey Light
• [Ip-health] Brazilian deal on tenofovir - translation of MoH release of 9th of may   MSF Michel Lotrowska
• [Ip-health] Andrew Pollack...Eli Lilly & Company infringed a patent covering body's basic biological pathways   James Love
• [Ip-health] US financing of R&D for bird flu   James Love
• [Ip-health] Eli Lilly challenge Australian PBS under FTA rules   James Love
• [Ip-health] Brazil: Expenses reignite discussions over patents on HIV drugs- 4 lang en/fr/sp/p   James Love
• [Ip-health] Huffpo: Eli Lilly uses US/Australia trade pact to push for higher prices on osteoporosis drug Forteo   James Love
• [Ip-health] WHO Prize Fund article: Drug development incentives to improve access to essential medicines   James Love
• [Ip-health] CPTech comments on the UK Gowers Review of intellectual property rights   James Love
• [Ip-health] Text of Kennedy, Stevens, Souter, Breyer concurring opinion in eBay, Inc. v. MercExchange, LLC   James Love
• [Ip-health] Congressman to Secretary Leavitt on WHA R&D resolution   James Love
• [Ip-health] John Mack on IMS efforts to defend use of physician prescribing data for marketing purposes   James Love
• [Ip-health] Wed noon comment on WHA R&D resolution   James Love
• [Ip-health] EU Discussion Papaer on Abuse of Dominanace - IP Refusal to License   James Love
• [Ip-health] IFPMA use of industry front group "Civil Society Report" in WHA debate   James Love
• [Ip-health] WHA negotiations update   James Love
• [Ip-health] Key part of WHA R&D resolution   James Love
• [Ip-health] IP-Watch on CIPIH and R&D resolutions   James Love
• [Ip-health] IPN is not a front group, is CPTech?   James Love
• [Ip-health] It's out.... no brackets, and it's a very good resolution   James Love
• [Ip-health] Friday's NGO quotes on R&D resolution   James Love
• [Ip-health] New CIPIH/R&D Resolution was just approved   James Love
• [Ip-health] CPTech Press Release on WHA CIPIH/R&D Resolution   James Love
• [Ip-health] Bush Administration plays very positive role in UN debate over R&D and access to medicine | The Huffington Post   James Love
• [Ip-health] Financial Times: WHO to prompt R&D for poorer countries   James Love
• [Ip-health] Abbott Labs. v. Teva -- blocking the introduction of generic fenofibrate by changing the product   James Love
• [Ip-health] Le Monde Diplomatique: A new initiative at the WHO   James Love
• [Ip-health] Lilly loses patent case that could shake up drug makers   Kent Nnadozie
• [Ip-health] WSJ: Selling Generic Drugs by Mail Turns Into Lucrative Business   Amy Nunn
• [Ip-health] WSJ: Eli Lilly Faces Patent Challenge From a Long-Ago Collaboration   Amy Nunn
• [Ip-health] Washington Post: Production of Anthrax Vaccine Delayed Again   Amy Nunn
• [Ip-health] NYT: The Higher Cost of Breathing (Amy Nunn)   Amy Nunn
• [Ip-health] WSJ: Despite Hope, Decade of Delay Afflicts Drug to Prevent AIDS (Amy Nunn)   Amy Nunn
• [Ip-health] WSJ: Merck, Harvard Sign Research Pact to License Eye-Disease Treatments   Amy Nunn
• [Ip-health] San Jose Mercury News: One Pill a Day for AIDS in Works   Amy Nunn
• [Ip-health] WSJ: Gates Donates $104 Million to TB Charity   Amy Nunn
• [Ip-health] Washington Post: Bird Flu Fears Ignite Debate on Scientists' Sharing of Data   Amy Nunn
• [Ip-health] AP: Drug makers delay generics hitting market   Amy Nunn
• [Ip-health] WSJ: FDA Approves Copycat Growth Hormone   Amy Nunn
• [Ip-health] CIEL vacancy on intellectual property   Maria Julia Oliva
• [Ip-health] SGAC: Abbott Promises Shareholders Expanded AIDS Drug Access, But Fails to Deliver, Activists Protest   Mike Palmedo
• [Ip-health] 15 News stories from the Philippines on Pfizer lawsuit   Mike Palmedo
• [Ip-health] AP: Draft of pandemic flu plan predicts huge impact   Mike Palmedo
• [Ip-health] Ecsatsy and Agony: The Current State of the Pharmaceutical Industry   Mike Palmedo
• [Ip-health] Excerpts from Pfizer's lawsuit against the Philippines and two of its government's employees   Mike Palmedo
• [Ip-health] NY Times: Generic Smear Campaign   Mike Palmedo
• [Ip-health] Groups call for ethics investigation into Tauzin's role in pro-pharma provisions in Medicare Part D   Mike Palmedo
• [Ip-health] Principale Administrator of EC DG Trade on WTO Decision of 6 December 2005 on the Amendment of the TRIPs Agreement   Mike Palmedo
• [Ip-health] Gilead press release on tenfovir in India   Mike Palmedo
• [Ip-health] Patent War: Will AIDS Cost You Dearer?   Mike Palmedo
• [Ip-health] AIDS Healthcare Foundation: AHF Applauds Gilead Sciences for Move to Increase Global Access to Affordable AIDS Drug   Mike Palmedo
• [Ip-health] Philippines Executive Order 442   Mike Palmedo
• [Ip-health] Philippine Daily Inquirer on Pfizer Case and McKinnell   Mike Palmedo
• [Ip-health] Korean Govt. Official's column on FTA Negotiations with US   Mike Palmedo
• [Ip-health] AFP: Kenya, Brazil Press for Funds for Neglected Diseases   Mike Palmedo
• [Ip-health] AP: US Drug Company Accused Of Making HIV Meds Unaffordable In India   Mike Palmedo
• [Ip-health] Speech by Pfizer CEO McKinnell on Pharmaceutical Research in India   Mike Palmedo
• [Ip-health] Pfizer Chairman McKinnell Meets Indian Prime Minister   Mike Palmedo
• [Ip-health] Manilla Times - Drug Delusions at the WHO   Mike Palmedo
• [Ip-health] Former Bush Aide and USAID Lawyer on WHO CIPIH Report   Mike Palmedo
• [Ip-health] Sci.Dev.net: Brazil and Kenya Press for Neglected Disease Research   Mike Palmedo
• [Ip-health] Voice of America article and interview with MSF on R&D Resolution at WHA   Mike Palmedo
• [Ip-health] UPI on Neglected Diseases, and on a Lieberman bill to extend patents   Mike Palmedo
• [Ip-health] Elimination of Neglected Diseases Act of 2006   Mike Palmedo
• [Ip-health] American Enterprise Institute Event on US-Chile FTA   Mike Palmedo
• [Ip-health] Nature: Neglected tests for neglected patients   Mike Palmedo
• [Ip-health] SF Chronicle: A Look At Gilead's Story of Supplying AIDS Patients   Mike Palmedo
• [Ip-health] Al Jazeera: Work Urged on Neglected Diseases   Mike Palmedo
• [Ip-health] Industry views presented to EC on WHA R&D resolution - and EC position on the resolution   Mike Palmedo
• [Ip-health] EC Position on the Executive Board Resolution on R&D   Mike Palmedo
• [Ip-health] IP-Watch: Health Assembly To Begin Talks On IP Resolutions Thursday Under Time Constraints   Mike Palmedo
• [Ip-health] IP-Watch: World Health Assembly Debates New Draft Text Merging IP Resolutions   Mike Palmedo
• [Ip-health] Patent Baristas: WHO Releases Report Promoting Innovation Relevant to Developing Countries   Mike Palmedo
• [Ip-health] Panel Faults Pfizer in '96 Clinical Trial In Nigeria,Unapproved Drug Tested on Children   Joana Ramos
• [Ip-health] Wary of Backlash, Cancer-Drug Makers Weigh Price Limits   Joana Ramos
• [Ip-health] Von Eschenbach's goodbye party canceled over ethics concerns   Joana Ramos
• [Ip-health] IOL: WHO to examine drug patent system   Manon Ress
• [Ip-health] =?ISO-8859-1?Q?Le_Monde_Diplomatique:_une_br=E8che_dans_le_tout-?= =?ISO-8859-1?Q?brevets_?=   Manon Ress
• [Ip-health] SUNS: WHO holds seminar on IPR, Innovation and Public Health Commission report   Sangeeta
• [Ip-health] SUNS: Opposition to drug patents in India highlights access fears   Sangeeta
• [Ip-health] SUNS: Appeal for needs-driven R&D for neglected diseases   Sangeeta
• [Ip-health] SUNS: WHO DG to be elected in November, nominations start 1 June   Sangeeta
• [Ip-health] SUNS: An "exceptional" Health Assembly ends with several decisions   Sangeeta
• [Ip-health] SUNS: South American Ministers vow to avoid TRIPS-plus measures   Sangeeta
• [Ip-health] SUNS: Patents on smallpox drugs raise issue of access to South   Sangeeta
• [Ip-health] WHA establishes working group on IPRs and health R&D   Sangeeta
• [Ip-health] academic debate on likelihood of TB drug pipeline to generate new drugs   Tido vo Schoen-Angerer
• [Ip-health] DNDi ALERT: "Waking Up Governments for Research on Neglected Diseases"   Ann-Marie Sevcsik
• [Ip-health] DNDi Alert: Governments Wake Up at 59th World Health Assembly by Passing Resolution to Boost Research on Neglected Diseases   Ann-Marie Sevcsik
• [Ip-health] MSF Supports Opposition to Gilead's tenofovir Patent Application in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] The Guardian: Drug firms seek to stop generic HIV treatment   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] IHT: AIDS drug provokes patent battle in India   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF: Gov'ts Must Move Forward with R&D Framework at WHA   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] IHT: A WHO report finds system fails the poor   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] AFP: Drugs patent debate set to dominate annual WHO assembly   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] The Independent: Drug companies 'failing to meet health needs of world's poorest'   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF op-ed in FT: Patients =?UTF-8?B?4oCZIG5lZWRzIGFyZSB3aGF0IG11c3QgZHJpdmUgZHJ1ZyByZXNlYXJjaA==?=   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF on WHA Outcome   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] AFP: WHO assembly backs talks on 'neglected' disease research   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] DPA: WHO agree "breakthrough" deal to research and develop drugs   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] IPS: WHO Paves Way for Medicines for the Poor   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] International Policy Network's "Independence and Guiding Principles"   Martin Smith
• [Ip-health] International Policy Network's "Independence and Guiding Principles"   Martin Smith
• [Ip-health] International Policy Network's "Independence and Guiding Principles"   Martin Smith
• [Ip-health] Mark your calendar: CPTech Seminar with Kevin Outterson on Patent Buy-Outs (May 10)   Joy Spencer
• [Ip-health] May 10, 2006: CPTech Brown Bag Seminar with Kevin Outterson on "Patent Buy-Outs for Global Disease Innovation"   Joy Spencer
• [Ip-health] FINAL REMINDER: CPTech Brown Bag at 10:30AM with Kevin Outterson (TOMORROW)   Joy Spencer
• [Ip-health] Kevin Outterson Brown Bag for today CANCELLED - Postponed to another date   Joy Spencer
• [Ip-health] CALL FOR ABSTRACTS: Global Health and Development Conference at Stanford   Jennifer Staple
• [Ip-health] promoting innovation in Germany   Christian Wagner
• [Ip-health] Email alert - May issue of the WHO Bulletin   bulletin
• [Ip-health] Email alert - June issue of the WHO Bulletin   bulletin
• [Ip-health] "breaking patents"   g.m.dutfield@qmul.ac.uk
• [Ip-health] Oxfam urges the World Health Assembly to adopt resolutions to ensure access to medicine for poor countries   mksmith@Oxfam.org.uk
• [Ip-health] Church World Service op-ed on failure of SACU FTA talks   mpalmedo@cptech.org
• [Ip-health] Re: [A2k] IPR & competitiveness [Job and Growth Initiative] - EU Memo]   mpalmedo@cptech.org
• [Ip-health] Korea Times: Swollen Drug Prices - US Intervention Neither Understandable Nor Acceptable   mpalmedo@cptech.org
• [Ip-health] New Scientist on new, easier, unpatented method for Tamiflu production   mpalmedo@cptech.org
• [Ip-health] India: Patents (Amendment) Rules 2006 notified   prabhu ram
• [Ip-health] Poisonous Tree Frog Could Bring Wealth to Tribe in Brazilian Amazon   prabhu ram
• [Ip-health] Local production and US bird flu financing   robert weissman
• [Ip-health] Health experts: combination pills for stroke and heart attack key for developing world   robert weissman
• [Ip-health] Drug Expenditure in Canada   robert weissman
• [Ip-health] Tobacco, IP and U.S.-Malaysia FTA - Comments from Essential Action   robert weissman

Last message date: Wed May 31 19:51:37 2006
Archived on: Wed May 31 18:51:37 2006

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...